scholarly journals Does Season of Reported Dietary Intake Influence Diet Quality? Analysis From the Women’s Health Initiative

2019 ◽  
Vol 188 (7) ◽  
pp. 1304-1310
Author(s):  
Tracy E Crane ◽  
Yasmin Abdel Latif ◽  
Betsy C Wertheim ◽  
Lindsay N Kohler ◽  
David O Garcia ◽  
...  

Abstract We evaluated the role of seasonality in self-reported diet quality among postmenopausal women participating in the Women’s Health Initiative (WHI). A total of 156,911 women completed a food frequency questionnaire (FFQ) at enrollment (1993–1998). FFQ responses reflected intake over the prior 3-month period, and seasons were defined as spring (March–May), summer (June–August), fall (September–November), and winter (December–February). FFQ data were used to calculate the Alternate Healthy Eating Index (AHEI), a measure of diet quality that has a score range of 2.5–87.5, with higher scores representing better diet quality. In multivariable linear regression models using winter as the reference season, AHEI scores were higher in spring, summer, and fall (all P values < 0.05); although significant, the variance was minimal (mean AHEI score: winter, 41.7 (standard deviation, 11.3); summer, 42.2 (standard deviation, 11.3)). Applying these findings to hypothesis-driven association analysis of diet quality and its relationship with chronic disease risk (cardiovascular disease) showed that controlling for season had no effect on the estimated hazard ratios. Although significant differences in diet quality across seasons can be detected in this population of US postmenopausal women, these differences are not substantial enough to warrant consideration in association studies of diet quality.

2014 ◽  
Vol 114 (7) ◽  
pp. 1036-1045 ◽  
Author(s):  
Melanie D. Hingle ◽  
Betsy C. Wertheim ◽  
Hilary A. Tindle ◽  
Lesley Tinker ◽  
Rebecca A. Seguin ◽  
...  

Endocrinology ◽  
2012 ◽  
Vol 153 (8) ◽  
pp. 3564-3570 ◽  
Author(s):  
Pauline M. Maki

Evidence from preclinical studies, randomized clinical trials (RCT), and observational studies underscores the importance of distinguishing among the different forms of estrogen and progestogens when evaluating the cognitive effects of hormone therapy (HT) in women. Despite this evidence, there is a lack of direct comparisons of different HT regimens. To provide insights into the effects of different HT formulations on cognition, this minireview focuses on RCT of verbal memory because evidence indicates that HT affects this cognitive domain more than others and because declines in verbal memory predict later development of Alzheimer's disease. Some observational studies indicate that estradiol confers benefits to verbal memory, whereas conjugated equine estrogens (CEE) confer risks. RCT to date show no negative impact of CEE on verbal memory, including the Women's Health Initiative Study of Cognitive Aging. Similarly, the Women's Health Initiative Memory Study showed no negative impact of CEE on dementia. Transdermal estradiol in younger postmenopausal women improved verbal memory in one small RCT but had no effect in another RCT. RCT of oral estradiol in younger and older postmenopausal women had neutral effects on cognitive function. In contrast, RCT show a negative impact of CEE plus medroxyprogesterone acetate on verbal memory in younger and older postmenopausal women. Small RCT show neutral or beneficial effects of other progestins on memory. Overall, RCT indicate that type of progestogen is a more important determinant of the effects of HT on memory than type of estrogen.


Sign in / Sign up

Export Citation Format

Share Document